تفكير حول الوضع الحالي ومسارات تطوير نقل تقنية الطب الصيني التقليدي من منظور التحول الذكي الرقمي

  • role: First author第一作者
  • Affiliation:

    Technology Cooperation Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

  • Email:zhangjie@chian-tcm.com
  • Introduction:E-mailzhangjie@chian-tcm.com
ZHANG Jie1,  
  • role: Corresponding author通信作者
  • Affiliation:

    Beijing Information Science and Technology University, Beijing 102206, China

  • Email:1095441416@qq.com
  • Introduction:E-mail1095441416@qq.com
XU Jing2*,  
  • Affiliation:

    Technology Cooperation Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

ZHENG Guangwei1,  
  • Affiliation:

    Technology Cooperation Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

ZHANG Huayu1,  
  • Affiliation:

    Technology Cooperation Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

LIU Chang1,  
  • Affiliation:

    Technology Cooperation Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

WEN Xiaoxiao1,  
  • Affiliation:

    Technology Cooperation Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

PAN Xishui1,  
  • role: Corresponding author通信作者
  • Affiliation:

    Technology Cooperation Center of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China

  • Email:wangbin135@139.com
  • Introduction:E-mailwangbin135@139.com *
WANG Bin1*

ملخص

باعتبار الطب الصيني التقليدي موردًا فريدًا للحضارة الصينية، تواجه عمليات نقل تقنياته في ظل التحول الذكي الرقمي فرصًا كبيرة، لكنها تخضع أيضًا لتحديات خاصة مثل تعقيد النظام النظري، طول سلسلة الصناعة، والقيود متعددة الأبعاد للسياسات، مما يخلق تناقضًا "عالي القيمة - عالي الحاجز". حاليًا، يعاني نقل تقنية الطب الصيني التقليدي من مأزق "عدم الرغبة في النقل، عدم القدرة على النقل، وعدم المعرفة بالنقل": حيث تفصل نظام تقييم البحث العلمي عن السوق مما يؤدي إلى عدم كفاية معدل تحويل النتائج؛ وعدم وضوح الملكية ومخاطر الامتثال تكبح دوافع الابتكار؛ نقص الخدمات المتخصصة يزيد من عدم التوافق بين العرض والطلب. تحلل المقالة خصوصيات هذه القضية بشكل منهجي وتقدم تحولًا قائمًا على التحول الرقمي الشامل في سلسلة القيمة كنقطة اختراق. عبر دمج تقنيات مثل نظام الفرز الذكي، تتبع البلوكتشين، ونماذج التشخيص والعلاج بالذكاء الاصطناعي، يتم إعادة تشكيل نظام زراعة وإنتاج وخدمة الأدوية الصينية. فيما يخص نظام المعايير، يتم دفع "بيانات الخبرة - توحيد البيانات - الذكاء المعياري" لكسر مشكلة السيطرة على الجودة، مثل نظام الاعتماد "ثلاثة بلا وواحد كامل" لتعزيز ثقة الجودة. يتطلب التنسيق السياسي تحسين آلية تحويل نتائج البحث العلمي، واستكشاف نماذج توريق الملكية الفكرية وتقاسم المخاطر لتنشيط الدافعية البحثية. ينبغي للاستراتيجية الدولية الاعتماد على منصة مبادرة الحزام والطريق لدفع علامة تجارية وتصدير معايير المواد الدوائية الأصلية، وبناء نموذج قيادة مزدوج "تكنولوجيا + ثقافة". في المستقبل، يحتاج الأمر إلى بناء قاعدة بيانات وطنية، وتنمية المواهب متعددة التخصصات، والاعتراف المتبادل بالمعايير الدولية لتشكيل نموذج جديد لـ"الصناعة الذكية والعلمية"، مع توفير حلول نظامية لتحديث الطب الصيني والحكم الصحي العالمي.

مفهوم

الطب الصيني التقليدي؛ الطب الصيني الذكي الرقمي؛ نقل التقنية؛ نتائج العلوم والتكنولوجيا؛ تقييم النتائج

References

  1. 1.
    LAM W C,LYU A P,BIAN Z X.ICD-11:Impact on traditional Chinese medicine and world healthcare systems[J].Pharm Med,2019,33(5):373-377.
  2. 2.
    REDDY B,FAN A Y.Incorporation of complementary and traditional medicine in ICD-11[J].BMC Med Inform Decis Mak,2021,21(S6):381.
  3. 3.
    LIANG D,ZHANG H.Research on technology transfer promoting industrial upgrading and transformation[J].Taiyuan Sci Technol,2024,45(12):9-11.
  4. 4.
    NIU P,TAN Y.Development status and practical experience of international technology transfer and cooperation:Taking Sichuan province as an example[J].Decis Mak Consul,2024(3):49-52.
  5. 5.
    LI Y W,CHI Y H,ZHU M T,et al.Efficacy of Kegan Liyan oral liquid vs.Lianhuaqingwen capsules for patients with mild COVID-19:A double-blinded,randomized,controlled,non-inferiority trial[J].Front Med,2025,12:1531370.
  6. 6.
    WANG K,GAO Y H,WANG G,et al.Network pharmacology study on the intervention mechanism of Lianhuaqingwen capsule in COVID-19 inflammation[J].J Yantai Univ:Nat Sci Eng Ed,2022,35(4):413-420.
  7. 7.
    WEI Z K,HAN Q,XUE Q L,et al.Analysis of quality traceability system for Chinese medicinal materials in Hebei Province[J].Co-Oper Econom Sci,2021(2):110-112.
  8. 8.
    CHEN J F,GUO C H,WEI W."Internet plus traditional Chinese medicine":Reconstructing the development model of the entire industrial chain of traditional Chinese medicine[J].China Soft Sci,2016(6):26-38.
  9. 9.
    JIA C L,ZHAO K J,ZHANG F,et al.Construction and application of quality traceability system for Chinese medicine decoction pieces[J].Mod Chin Med,2024,26(6):1092-1098.
  10. 10.
    CUI T,HE J J,HE H,et al.Research on tongue image features based on deep learning[J].J Med Inform,2024,45(7):81-87.
  11. 11.
    LIU J Y,LAI H H,PAN B,et al.Application prospects and challenges of generative artificial intelligence in the standardization research of traditional Chinese medicine[J].Shanghai J Tradit Chin Med,2025,59(4):1-7,54.
  12. 12.
    CHEN Z J,PENG W Q,ZHANG D Z,et al.Application,challenges and prospects of large language models in the field of traditional Chinese medicine[J].Med J Peking Union Med Coll Hosp,2025,16(1):83-89.
  13. 13.
    BAI L L,ZHANG H X,PAN X L.Analysis of the development status and industrial trends of intelligent acupuncture devices[J].Lishizhen Med Mater Med Res,2024,35(9):2239-2243.
  14. 14.
    ZHANG C C,YANG G.Discussion on the current situation,problems and countermeasures of endangered Chinese medicinal materials management[J].Chin J Chin Mater Med,2025,50(14):4081-4088.
  15. 15.
    XIE Y M,WANG L X.Clinical and social value of traditional Chinese medicine research:On the transformation of scientific and technological achievements of traditional Chinese medicine[J].J Tradit Chin Med,2015,56(24):2079-2082.
  16. 16.
    ZHAO Y H,WANG C N,LI H J.Research on countermeasures for the transformation of scientific and technological achievements related to traditional Chinese medicine[J].Chin Med Manag Sci,2024,14(3):107-111.
  17. 17.
    CAI X J,TIAN N,YANG J L.Analysis of the dilemma and countermeasures in the internationalization process of Pien Tze Huang[J].Chin Foreign Entrepreneurs,2018(21):230.
  18. 18.
    WANG X W,ZHAO X S,TANG S S.Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction[J].Cell Stress Chaperones,2015,20(5):781-786.
  19. 19.
    LIU W,CHENG X M,GENG D M,et al.Interpretation of SCHWABE company's Ginkgo biloba preparation patent portfolio[J].China J Chin Mater Med,2014,39(17):3384-3388.
  20. 20.
    LI X.Influencing factors,evolution,and strategies for improving the quality of traditional Chinese medicine patents:An empirical study based on patent invalidation cases[J].Ann Med,2024,56(1):2422571.
  21. 21.
    ZHANG Z H,LI R R,CHEN Y,et al.Integration of traditional,complementary,and alternative medicine with modern biomedicine:The scientization,evidence,and challenges for integration of traditional Chinese Medicine[J].Acupunct Herb Med,2024,4(1):68-78.
  22. 22.
    ZHANG J,ZHANG Z M.The challenges of ethical review in clinical research of traditional Chinese medicine[J].Evid Based Complementary Altern Med,2021,2021:6754985.
  23. 23.
    RUAN J H,ZHANG W N,HU Z P.The connection between academic achievements and market demand:The role and practice of technology and innovation in knowledge transfer[J].Edelweiss Appl Sci Technol,2024,8(6):6165-6175.
  24. 24.
    ALKHAZALEH R,MYKONIATIS K,ALAHMER A.The success of technology transfer in the industry 4.0 era:A systematic literature review[J].J Open Innov Technol Mark Complex,2022,8(4):202.
  25. 25.
    SHEN C L.How to transform 600 traditional Chinese medicine achievements in one year[N].China Sci Daily,2024-01-22(04).
  26. 26.
    SHI S H,CHEN L X,ZHENG Y X,et al.Research on the current situation and countermeasures of patent management in traditional Chinese medicine universities from the perspective of achievement transformation:Taking 6 universities as examples[J].Chin Univ Sci Technol,2025(3):65-70.
  27. 27.
    ZHANG X L,CHEN Y M.WU Jiannong:Straightening the backbone of traditional Chinese medicine scientific research[J].Chin Hosp CEO,2025,21(2):58-59.
  28. 28.
    FANG J G.Hangzhou:Leading residents from "healthier" to "happier"[J].China Health,2025(4):12-14.
  29. 29.
    XINHUA NET."AI traditional Chinese medicine" prescribes! Nanjing University of Chinese Medicine research team launches "Huanghuang Jingfang AI-assisted diagnosis and treatment system"[EB/OL].(2025-03-14).[2025-02-20]..
  30. 30.
    TIAN G H,QIAN K,LI X Y,et al.Can a holistic view facilitate the development of intelligent traditional chinese medicine?A survey[J].IEEE Trans Comput Soc Syst,2023,10(2):700-713.
  31. 31.
    LI Y L,FAN J,CHENG X L,et al.New revolution for quality control of TCM in industry 4.0:Focus on artificial intelligence and bioinformatics[J].Trac Trends Anal Chem,2024,181(PB):118023.
  32. 32.
    GONG A J,GUO L B,YU Y,et al.Spectrum-image dual-modality fusion empowered accurate and efficient classification system for traditional Chinese medicine[J].Inf Fusion,2024,101:101981.
  33. 33.
    WU B,ZHANG L L,GUO Y A,et al.Research on the construction of TCM syndrome differentiation model for cancer pain based on artificial intelligence[J].China Arch Tradit Chin Med,2025,43(3):19-23,260.
  34. 34.
    WANG X Y,XIE Y,YANG X J,et al.Internet-based healthcare knowledge service for improvement of Chinese medicine healthcare service quality[J].Healthcare,2023,11(15):2170.
  35. 35.
    ZHAO W B,WANG B Y,LI S.Network pharmacology for traditional Chinese medicine in era of artificial intelligence[J].Chin Herb Med,2024,16(4):558-560.
  36. 36.
    LI D N,HU J,ZHANG L,et al.Deep learning and machine intelligence:New computational modeling techniques for discovery of the combination rules and pharmacodynamic characteristics of traditional Chinese medicine[J].Eur J Pharmacol,2022,933:175260.
  37. 37.
    KE Z P,LIU M X,LIU J,et al.The application of artificial intelligence in the research and development of traditional Chinese medicine[J].Int J Drug Discov Pharmacol,2024,3(1):100001.
  38. 38.
    WANG Y Q,HU K F,HU C J.Application and development of systems biology in the field of computer-aided drug design[J].Chin J Chin Mater Med,2023,48(11):2868-2875.
  39. 39.
    FAN Z R.Exploration and thinking on the concept of ecological planting of genuine medicinal materials to promote high-quality development of rural industries[J].Sichuan Agric Sci Technol,2024(9):120-122.
  40. 40.
    WANG Y,GUO Y,LIU H,et al.Quantitative analysis of national medicine strategic policies towards internationalization of traditional Chinese medicine[J].Tran Soc Sci,Edu Human Res,2023,1:151-158.
  41. 41.
    CHU X L,SUN B Z,HUANG Q C,et al.Quantitative knowledge presentation models of traditional Chinese medicine (TCM):A review[J].Artif Intell Med,2020,103:101810.

قراءة النص الكامل

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website